PPHvsJDOCETF Comparison
VS
VanEck Pharmaceutical ETF (PPH) belongs to the Uncategorized Equities segment. JPMorgan Healthcare Leaders ETF (JDOC) is part of the Global Blended Cap segment. PPH's top 1 sector exposures are Healthcare. In contrast, JDOC's top sector exposures are Healthcare and Consumer Non-Cyclicals. PPH is less expensive with a Total Expense Ratio (TER) of 0.36%, versus 0.65% for JDOC. PPH is up 13.41% year-to-date (YTD) with -$316M in YTD flows. JDOC performs worse with 9.81% YTD performance, and -$34K in YTD flows. Run a side-by-side ETF comparison of PPH and JDOC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PPH vs JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PPH JDOC | +4.67%+4.44% | +4.95%+4.93% | +13.41%+9.81% | +26.91%+16.60% | +57.53%n/a | +69.99%n/a |
| Flows | PPH JDOC | +$15M- | +$61M- | -$316M-$34K | -$397M-$34K | +$356M- | +$450M- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PPH JDOC | +19.86%+16.18% | +18.46%+15.60% | +16.43%n/a | +15.78%n/a |
| Max drawdown | PPH JDOC | -8.47%-7.92% | -10.78%-9.66% | -17.98%n/a | -20.19%n/a |
| Max drawdown duration | PPH JDOC | 59d59d | 122d154d | 434dn/a | 484dn/a |
Trading data
PPH | JDOC | |
Last sale 10/23/2026 at 1:30 PM | $114.93 | $63.67 |
| Previous close 10/22/2026 | $117.04 | $64.14 |
| Consolidated volume 10/22/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
JDOC
is actively managed and doesn’t replicate an indexPPH | JDOC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/23/2026 at 1:30 PM
Live
Closed
PPH | JDOC | |
|---|---|---|
| Last price | $114.93 | $63.67 |
| 1D performance | -1.80% | -0.73% |
| AuM | $1.06 B | $9.53 M |
| E/R | 0.36% | 0.65% |
Characteristics
PPH | JDOC | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VanEck | J.P. Morgan Asset Management |
| Benchmark | MVIS US Listed Pharmaceutical 25 Index | - |
| N° of holdings | 25 | 57 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 20, 2011 | November 1, 2023 |
| ESG | No | No |
Advertisement
Exposure
Countries
PPH
USA
62.46%
United Kingdom
10.95%
Switzerland
10.06%
Other
16.53%
JDOC
USA
73.86%
Other
26.14%
Sectors
PPH
Healthcare
100%
Other
0%
JDOC
Healthcare
96.33%
Other
3.67%
Advertisement
Diversification
PPH
Total weight of top 15 holdings out of 15
90.56%
JDOC
Total weight of top 15 holdings out of 15
59.39%
Top 15 holdings
Data as of August 31, 2026
PPH
Eli Lilly & Co.
19.11%
Merck & Co., Inc.
10.96%
Novartis AG
10.06%
Pfizer Inc.
5.05%
Bristol Myers Squibb Co.
4.98%
Novo Nordisk A/S
4.92%
McKesson Corp.
4.70%
AbbVie, Inc.
4.48%
Johnson & Johnson
4.43%
GSK Plc
4.13%
Sanofi
4.06%
Cencora, Inc.
3.68%
AstraZeneca PLC
3.59%
Haleon Plc
3.23%
Teva Pharmaceutical Industries Ltd.
3.17%
JDOC
AbbVie, Inc.
7.91%
Eli Lilly & Co.
7.63%
Merck & Co., Inc.
5.32%
Johnson & Johnson
4.80%
Thermo Fisher Scientific, Inc.
4.15%
UnitedHealth Group, Inc.
3.64%
Bristol Myers Squibb Co.
3.52%
AstraZeneca PLC
3.48%
Abbott Laboratories
3.15%
Novo Nordisk A/S
2.95%
Roche Holding AG
2.80%
argenx SE
2.79%
Danaher Corp.
2.56%
GSK Plc
2.47%
CVS Health Corp.
2.24%
Frequently asked questions about PPH and JDOC
How have the PPH and JDOC ETFs performed in 2026?
As of October 23, 2026, PPH is up 13.41% year-to-date (YTD), while JDOC has returned 9.81%. That puts PPH better performer ahead so far this year.
Which ETF is attracting more investor money: PPH or JDOC?
Year-to-date, the PPH ETF saw -$316M in flows, compared to -$34K for JDOC.
Which ETF is more volatile: PPH or JDOC?
Over the past year, PPH had a volatility of 18.46%, while JDOC experienced 15.6%.
Which ETF is bigger: PPH or JDOC?
As of October 23, 2026, PPH holds $1.06 B in assets under management (AUM), while JDOC manages $9.53 M.
What sectors do the PPH and JDOC ETFs invest in?
PPH leans toward sectors like Healthcare. Meanwhile, JDOC focuses on Healthcare.
What are the top holdings of the PPH ETF and JDOC ETF?
PPH top holdings include Eli Lilly & Co., Merck & Co., Inc. and Novartis AG. JDOC holds in its top three: AbbVie, Inc., Eli Lilly & Co. and Merck & Co., Inc..
Which ETF is more diversified: PPH or JDOC?
PPH holds 25 securities with 90.56% of its assets in the top 15. JDOC has 58 securities and a top 15 weight of 59.39%.
Advertisement
Latest news about PPH & JDOC
Healthcare Stocks Rebound
August 14, 2023
PPH
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
PPH
Trending sub-sectors in 2022
July 12, 2022
PPH
Advertisement
Advertisement
